Posted by Michael Wonder on 04 Jul 2023
Amneal launches authorised generic for Xyrem (sodium oxybate) and receives FDA approval for five complex generics in the second quarter
3 July 2023 - Launches authorized generic for Xyrem (sodium oxybate) in the US, representing another new complex generic product launch.
Amneal Pharmaceuticals today announced the launch of its authorised generic for Xyrem (sodium oxybate) oral solution CIII in the US.
